Triamcinolone Acetonide Intravitreal Injection
Last Updated: November 28, 2022
- Triesence intravitreal suspension for injection, Novartis, 40 mg/mL, 1 mL vial, NDC 00065-0543-01
- Novartis did not provide a reason for the shortage.
- There are no presentations available
Estimated Resupply Dates
- Novartis has Triesence 40 mg/mL 1 mL vials on back order and the company estimates a release date of 2nd quarter 2023.
Updated November 28, 2022 by Michelle Wheeler, PharmD, Drug Information Specialist. Created September 30, 2021 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2022, Drug Information Service, University of Utah, Salt Lake City, UT.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.